Standard Nuclear's shares rose 4.45% to $14.31 following a binding TRISO fuel supply agreement with Radiant Industries. The deal covers multiple metric tons of fuel for Kaleidos microreactors through 2031. The stock has gained 10.33% over seven days and 89.79% over 30 days. Recent fuel contracts and a new board appointment have driven this momentum. However, a DCF valuation model estimates Standard Nuclear's fair value at $9.42, suggesting the stock is overvalued by nearly $5 per share at current levels. The company reported a $14.97 million loss on $3.36 million revenue, with a market capitalisation of $2.20 billion. The valuation gap raises questions about whether the TRISO contract pipeline is already fully priced into the shares.

Standard Nuclear backlog reaches $576.9 million. * Standard Nuclear reported Q2 2026 revenue of $4.7 million, up from $0.6 million a year earlier. * Total contract backlog increased to $576.9 million after a new fuel supply agreement. * The company advanced TRISO fuel production facilities and completed a New York Stock Exchange IPO. Standard Nuclear (NYSE:STDN) reported second quarter 2026 revenue of $4.7 million, up from $0.6 million in the prior-year period, while total contract backlog later increased to $576.9 million following new customer agreements. The company reported total contract backlog of $241.5 million as of June 30, 2026, compared with $91.3 million on March 31, 2026, while funded backlog increased to $61.9 million from $8.2 million. Standard Nuclear Chief Executive Officer said the company continued converting its qualified pipeline into long-term contracts and advancing production capabilities, according to the company's earnings announcement. During the quarter, Standard Nuclear delivered 50 kgU of TRISO fuel and completed delivery of the remaining reactor core after quarter end, marking the first reactor core of commercially produced TRISO fuel supplied by an independent U.S. manufacturer, according to the company. Standard Nuclear stated that construction was substantially completed at its Tennessee and Idaho production facilities, with startup, commissioning, and authorization activities underway and operating authorization targeted for the fourth quarter of 2026. The company also completed an initial public offering on the New York Stock Exchange, adding approximately $137.7 million in net proceeds, and reported a pro forma debt-free balance sheet with approximately $239.9 million in cash. Frequently asked questions. STDN signals